Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination With AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)

NCT04885998 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT04885998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04885998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination With AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Lead sponsor
Amgen
Phase
Phase 1
Overall status
Completed
Start date
September 27, 2021
Completion date
September 11, 2024
Enrollment
23 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer